patent for semaglutide Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite New Delhi, March 19, 2026

31 Intranasal administration of Semax at 16 mg/kg in healthy adults improved decision-making, work site performance, mental acuity, short-term memory, and attention span, with results lasting up to 24 hours

When people drop weight quickly, as is often the case with GLP-1s, they are not just shedding fat but also lean body mass, which includes muscle

Its the corporate equivalent of throwing the cops the small bag while sitting on the big one

No confirmed causal relationship from tumor development has been established in peer-reviewed research

Nonprofit organizations such as the PAN Foundation and NeedyMeds may offer grants, discounts, or other resources for people who need assistance paying for medications

Potential adverse effects of resveratrol: A literature review